Medtronic InSync ICD Gains Panel Support In Tiebreaking 6-5 Vote

The recommended post-market requirement for Medtronic's InSync ICD and its pacing counterpart suggests that companies that conduct pivotal studies with a small number of patients will be expected to follow up with a large trial

More from Archive

More from Medtech Insight